West Pharmaceutical Services, Inc. (WST) Institutional Ownership & Insider Trading

830 institutions reported holding West Pharmaceutical Services, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 8 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

WSTWest Pharmaceutical Services, Inc.Follow WST — free

Medical Instruments & Supplies · Healthcare

—

Price chart with a free account

Market cap: 27.6B
P/E TTM: 50.2
Dividend yield: 0.2%
52-week: —
Next earnings: 29 Oct, in 5 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

830 institutions held —% of the shares. Across filers that reported both quarters, shares held changed -1.9%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	830	71	-1.9%	277	126	238	42
Mar 26	749	71	+2.8%	236	58	255	102
Dec 25	789	70	+0.2%	231	72	262	38
Sep 25	738	69	-1.1%	234	84	217	57
Jun 25	722	70	+0.4%	241	75	220	63
Mar 25	696	69	+0.3%	242	64	226	96
Dec 24	726	70	-0.7%	247	49	218	66
Sep 24	710	68	-0.3%	260	37	242	86

West Pharmaceutical Services, Inc. — questions

Who owns West Pharmaceutical Services, Inc. stock?: 830 institutions reported West Pharmaceutical Services, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (9.4%), VANGUARD CAPITAL MANAGEMENT LLC (6.6%), VANGUARD PORTFOLIO MANAGEMENT LLC (5.7%).
Are West Pharmaceutical Services, Inc. insiders buying or selling?: 8 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from West Pharmaceutical Services, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.